Andexanet Alfa Therapy Showed No Increased Rate of Thromboembolic Events in Spontaneous Intracranial Hemorrhage Patients: A Multicenter Electronic Health Record Study

Authors

John Vellek, New York Medical College
Omar H. Tarawneh, New York Medical College
Syed Faraz Kazim, University of New Mexico Hospital
Oluwafemi P. Owodunni, University of New Mexico Hospital
Sophia Arbuiso, New York Medical College
Smit Shah, University of South Carolina School of Medicine Columbia
Alis J. Dicpinigaitis, New York Medical College
Meic H. Schmidt, University of New Mexico Hospital
Rohini G. McKee, UNM School of Medicine
Richard Miskimins, UNM School of Medicine
Fawaz Al-Mufti, New York Medical College
Christian A. Bowers, Bowers Neurosurgical Frailty and Outcomes Data Science Lab

Author Type(s)

Student, Faculty

DOI

10.1016/j.wnsx.2024.100367

Journal Title

World Neurosurgery X

Document Type

Article

Publication Date

7-1-2024

Department

Neurology

Keywords

Andexanet Alfa, Anticoagulation, Intracranial Hemorrhage, Thromboembolism

Disciplines

Medicine and Health Sciences

Recommended Citation

Vellek, J., Tarawneh, O., Kazim, S., Owodunni, O., Arbuiso, S., Shah, S., Dicpinigaitis, A., Schmidt, M., McKee, R., Miskimins, R., Al-Mufti, F., & Bowers, C. (2024). Andexanet Alfa Therapy Showed No Increased Rate of Thromboembolic Events in Spontaneous Intracranial Hemorrhage Patients: A Multicenter Electronic Health Record Study. World Neurosurgery X, 23. https://doi.org/10.1016/j.wnsx.2024.100367